Literature DB >> 2054355

The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution.

C Weber1, G Wider, B von Freyberg, R Traber, W Braun, H Widmer, K Wüthrich.   

Abstract

Cyclosporin A bound to the presumed receptor protein cyclophilin was studied in aqueous solution at pH 6.0 by nuclear magnetic resonance spectroscopy using uniform 15N- or 13C-labeling of cyclosporin A and heteronuclear spectral editing techniques. Sequence-specific assignments were obtained for all but one of the cyclosporin A proton resonances. With an input of 108 intramolecular NOEs and four vicinal 3JHN alpha coupling constants, the three-dimensional structure of cyclosporin A bound to cyclophilin was calculated with the distance geometry program DISMAN, and the structures resulting from 181 converged calculations were energy refined with the program FANTOM. A group of 120 conformers was selected on the basis of the residual constraint violations and energy criteria to represent the solution structure. The average of the pairwise root-mean-square distances calculated for the backbone atoms of the 120 structures was 0.58 A. The structure represents a novel conformation of cyclosporin A, for which the backbone conformation is significantly different from the previously reported structures in single crystals and in chloroform solution. The structure has all peptide bonds in the trans form, contains no elements of regular secondary structure and no intramolecular hydrogen bonds, and exposes nearly all polar groups to its environment. The root-mean-square distance between the backbone atoms of the crystal structure of cyclosporin A and the mean of the 120 conformers representing the NMR structure of cyclosporin A bound to cyclophilin is 2.5 A.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054355     DOI: 10.1021/bi00240a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Design criteria for molecular mimics of fragments of the beta-turn. 2. C alpha-C beta bond vector analysis.

Authors:  S L Garland; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

2.  An improved double-tuned and isotope-filtered pulse scheme based on a pulsed field gradient and a wide-band inversion shaped pulse.

Authors:  K Ogura; H Terasawa; F Inagaki
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

3.  Kinetics and mechanism of isomerization of cyclosporin A.

Authors:  R Oliyai; V J Stella
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

4.  Structures of protonated arginine dimer and bradykinin investigated by density functional theory: further support for stable gas-phase salt bridges.

Authors:  E F Strittmatter; E R Williams
Journal:  J Phys Chem A       Date:  2000-06-29       Impact factor: 2.781

Review 5.  Molecular recognition: models for drug design.

Authors:  R J Breckenridge
Journal:  Experientia       Date:  1991-12-01

6.  Crystal structure of recombinant human T-cell cyclophilin A at 2.5 A resolution.

Authors:  H M Ke; L D Zydowsky; J Liu; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

7.  NMR structure-based drug design.

Authors:  S W Fesik
Journal:  J Biomol NMR       Date:  1993-05       Impact factor: 2.835

8.  The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.

Authors:  D Braaten; H Ansari; J Luban
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

9.  1H and 13C-NMR and molecular dynamics studies of cyclosporin a interacting with magnesium(II) or cerium(III) in acetonitrile. Conformational changes and cis-trans conversion of peptide bonds.

Authors:  Francesca Bernardi; Elena Gaggelli; Elena Molteni; Elena Porciatti; Daniela Valensin; Gianni Valensin
Journal:  Biophys J       Date:  2005-11-18       Impact factor: 4.033

10.  Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.

Authors:  E K Franke; B X Chen; I Tatsis; A Diamanduros; B F Erlanger; J Luban
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.